The Next Frontier in Biomedical Engineering
Congenital heart disease (CHD) affects nearly nine in every 1,000 babies born. In fact, it’s the world’s most common birth defect. Researchers and clinicians today have begun applying stem cell therapies and 3D tissue printing to pediatric heart defects. Michael Davis, director of the Children’s Heart Research and Outcomes Center (HeRO) under the Georgia Tech and Emory University’s Department of Biomedical Engineering, is busy pushing the boundaries on innovative stem cell research with clinical trials, predictive medicine models and 3D printing.
Click here to continue reading.